ESR1, PGR, ERBB2, and MKi67 mRNA expression in diagnostic core biopsies from breast cancer patients of the ABCSG Trial 34.

Saved in:
Bibliographic Details
Title: ESR1, PGR, ERBB2, and MKi67 mRNA expression in diagnostic core biopsies from breast cancer patients of the ABCSG Trial 34.
Authors: Kacerovsky-Strobl S; Department of Surgery, Klinikum Donaustadt, Vienna, Austria; Austrian Breast and Colorectal Cancer Study Group (ABCSG), Vienna, Austria., Deutschmann C; Austrian Breast and Colorectal Cancer Study Group (ABCSG), Vienna, Austria; Department of Obstetricss and Gynecology, Division of Oncology, Breast Health Center and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Hlauschek D; Austrian Breast and Colorectal Cancer Study Group (ABCSG), Vienna, Austria., Bago-Horvath Z; Department of Pathology, Division of Oncology, Breast Health Center and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Singer CF; Austrian Breast and Colorectal Cancer Study Group (ABCSG), Vienna, Austria; Department of Obstetricss and Gynecology, Division of Oncology, Breast Health Center and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Bartsch R; Department of Medicine I, Division of Oncology, Breast Health Center and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Greil R; 3rd Medical Department, Salzburg Cancer Research Institute, Cancer Cluster Salzburg, Paracelsus Medical University Salzburg, Salzburg, Austria., Sotlar K; Institute of Pathology, Paracelsus Medical University Salzburg, Salzburg, Austria., Rinnerthaler G; Departments of Division of Oncology, Department of Internal Medicine, Medical University Graz, Graz, Austria., Petru E; Department of Gynecology and Obstetrics, Medical University Graz, Graz, Austria., Lax SF; Department of Pathology, Hospital Graz II, Graz, Austria; Johannes Kepler University Linz, Linz, Austria., Egle D; Department of Gynecology and Obstetrics, Medical University Innsbruck, Innsbruck, Austria., Pichler A; Departments of Hemato-Oncology, LKH Hochsteiermark-Leoben, Leoben, Austria., Bodó K; Departments of Pathology, LKH Hochsteiermark-Leoben, Leoben, Austria., Petzer AL; Departments of Internal Medicine I, Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz Barmherzige Schwestern, Elisabethinen, Linz, Austria., Moinfar F; Departments of Pathology, Ordensklinikum Linz Barmherzige Schwestern, Elisabethinen, Linz, Austria., Weidler J; Cepheid, Sunnyvale, CA, USA., Bates M; Cepheid, Sunnyvale, CA, USA., Dubsky P; St. Anna Breast Center, Hirslanden Klinik St. Anna, Lucerne, Switzerland; University of Lucerne, Faculty of Health Sciences and Medicine, Lucerne, Switzerland., Gnant M; Austrian Breast and Colorectal Cancer Study Group (ABCSG), Vienna, Austria; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Filipits M; Austrian Breast and Colorectal Cancer Study Group (ABCSG), Vienna, Austria; Center for Cancer Research, Breast Health Center and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. Electronic address: martin.filipits@meduniwien.ac.at.
Source: Breast (Edinburgh, Scotland) [Breast] 2025 Dec; Vol. 84, pp. 104633. Date of Electronic Publication: 2025 Oct 30.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-3080
DOI:10.1016/j.breast.2025.104633